MAML3 Antikörper (full length)
Kurzübersicht für MAML3 Antikörper (full length) (ABIN5707997)
Target
Alle MAML3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- MAML3 Antibody (azide and preservative free)
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A human full length recombinant protein was used as the immunogen for this MAML3 antibody.
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the MAML3 antibody to be titered up or down for optimal performance.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the MAML3 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- MAML3 (Mastermind-Like 3 (MAML3))
-
Andere Bezeichnung
- MAML3
-
Hintergrund
- Mastermind-like 3 is a nuclear speckle protein that acts as a transcriptional coactivator for Notch receptors. The Notch signaling pathway influences cell fate by regulating the ability of precursor cells to properly respond to developmental signals. MAML3 is a member of the mastermind-like family of proteins that are human homologs of the Drosophila melanogaster mastermind protein. Through its N-terminal region, MAML3 interacts with the ankyrin repeats of the Notch 1-4 proteins. This interaction leads to formation of a DNA-binding complex with the Notch proteins and RBP-Ji°, a complex that can then induce HES1 gene expression. While the N-terminal domain of MAML3 is essential for proper Notch binding, the C-terminal domain is essential for transcriptional activation. Due to its involvement in cell signaling and transcriptional activation, its upregulation is thought to be involved in oncogenesis.
Target
-